Anavex Life Sciences Corp. (AVXL)
2.99
-0.11
(-3.55%)
USD |
NASDAQ |
Apr 02, 16:00
2.99
0.00 (0.00%)
After-Hours: 20:00
Anavex Life Sciences Free Cash Flow : -34.08M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Becton, Dickinson & Co. | 2.631B |
| Nephros, Inc. | 1.645M |
| Cabaletta Bio, Inc. | -132.31M |
| ACADIA Pharmaceuticals, Inc. | 6.308M |
| Alnylam Pharmaceuticals, Inc. | 465.38M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -7.151M |
| Cash from Financing (Quarterly) | 36.32M |
| Free Cash Flow Per Share (Quarterly) | -0.0803 |
| Free Cash Flow to Equity (Quarterly) | -7.151M |
| Free Cash Flow to Firm (Quarterly) | -7.151M |
| Free Cash Flow Yield | -13.64% |